A propensity-matched analysis of stereotactic body radiotherapy and sublobar resection for stage I non-small cell lung cancer in patients at high risk for lobectomy: the results in a Chinese population

CONCLUSIONS: Disease control and survival in the SBRT patients was equivalent to that seen in SLR patients with stage I NSCLC considered high-risk lobectomy candidates. SBRT could therefore be an alternative option to SLR in treating patients with a high operative risk.PMID:33841971 | PMC:PMC8024811 | DOI:10.21037/jtd-21-339
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Authors: Source Type: research